Bank of Montreal
SYRE icon

Bank of Montreal’s Spyre Therapeutics SYRE Stock Holding History

Bank of Montreal’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-149
Closed -$29K – 4826
2021
Q1 		$29K Sell
149
-228
-60% -$43.7K ﹤0.01% 3918
2020
Q4 		$74K Buy
377
+205
+119% +$42.5K ﹤0.01% 3744
2020
Q3 		$33K Sell
172
-44
-20% -$8.14K ﹤0.01% 3601
2020
Q2 		$48K Buy
216
+148
+218% +$28.2K ﹤0.01% 3465
2020
Q1 		$7K Sell
68
-133
-66% -$22.6K ﹤0.01% 3606
2019
Q4 		$38K Buy
201
+42
+26% +$8.24K ﹤0.01% 3983
2019
Q3 		$31K Sell
159
-111
-41% -$21.6K ﹤0.01% 3851
2019
Q2 		$47K Buy
270
+145
+116% +$25.1K ﹤0.01% 3728
2019
Q1 		$25K Sell
125
-7
-5% -$1.46K ﹤0.01% 3591
2018
Q4 		$25K Sell
132
-77
-37% -$16.3K ﹤0.01% 3565
2018
Q3 		$50K Buy
209
+82
+65% +$19.2K ﹤0.01% 3392
2018
Q2 		$33K Sell
127
-110
-46% -$27.1K ﹤0.01% 3585
2018
Q1 		$59K Buy
237
+117
+98% +$21.1K ﹤0.01% 3171
2017
Q4 		$16K Buy
120
+119
+11,900% +$14.6K ﹤0.01% 3652
2017
Q3 		$0 Hold
1
– – ﹤0.01% 4319
2017
Q2 		$0 Buy
+1
New +$138 ﹤0.01% 4282
2017
Q1 		– Sell
-1
Closed – – 4178
2016
Q4 		$0 Buy
+1
New +$146 ﹤0.01% 4187

Other funds holding SYRE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bank of Montreal's SYRE Position: Q2 2021 in Review

Bank of Montreal sold out of Spyre Therapeutics (SYRE) in Q2 2021, closing a stake of 149 shares — an estimated $29K sold.

Bank of Montreal first reported a position in SYRE in Q4 2016 and held it in 17 quarters. The position peaked at $74K in Q4 2020. 78 funds tracked by Wall St. Rank hold SYRE as of Q2 2021.

  • Bank of Montreal reported no remaining Spyre Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 149 Spyre Therapeutics shares in Q2 2021, an estimated $29K.
  • Bank of Montreal first reported a position in Spyre Therapeutics in Q4 2016 and held it in 17 quarters.
  • Bank of Montreal's Spyre Therapeutics position peaked at $74K in Q4 2020.
  • 78 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.